RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration, announced that GtreeBNT, the licensee for several RegeneRx products, is being acquired by HLB Group, a Korean company that includes six biopharmaceutical and financial subsidiaries in Korea and the U.S.   As part of the acquisition GtreeBNT will issue approximately $80 million of new stock and convertible bonds to HLB Group to fund ongoing programs. The new capita...